title: Plasma lipids, lipoproteins and atherogenic index in men and women administered vitamin C.
abstract: The aim of the study was to establish whether it is possible, in a group of deliberately selected subjects with hyperlipidaemia, to modulate cholesterol levels by ascorbic acid administered at a dose of 500 mg/day. The authors assessed the levels of vitamin C, total and HDL cholesterol, triacylglycerols in the blood serum of 140 probands assigned to an 83-member experimental group, and to a 57-member control group. The experimental group was provided Celaskon effervescens Spofa at a dose of 500 mg/day/person. The experiment lasted for 18 months. Blood collections were made in the whole cohort at six-month intervals. Administration of L-ascorbic acid led to a highly significant decrease in the levels of total and LDL cholesterol. After 12 months of study, a highly significant decrease in atherogenic index and an increase in HDL cholesterol levels were found persisting until the end of the experiment.
authors.affiliation: Research Institute of Human Nutrition, Comenius University College of Physical Education, Bratislava, Czechoslovakia.
authors.forename: O
authors.initials: O
authors.lastname: Cerná
authors.forename: L
authors.initials: L
authors.lastname: Ramacsay
authors.forename: E
authors.initials: E
authors.lastname: Ginter
mesh_terms: D001161:Arteriosclerosis / Q000097:blood*; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol; D001205:Ascorbic Acid